Search Results - "Toutirais, O."

Interleukin‐6 and vascular endothelial growth factor release by renal cell carcinoma cells impedes lymphocyte–dendritic cell cross‐talk by Cabillic, F., Bouet‐Toussaint, F., Toutirais, O., Rioux‐Leclercq, N., Fergelot, P., De La Pintière, C. Thomas, Genetet, N., Patard, J.‐J., Catros‐Quemener, V.

“…Summary Anti‐tumour T cell response requires antigen presentation via efficient immunological synapse between antigen presenting cells, e.g. dendritic cells…”
Get full text

Effects of CD40 binding on ovarian carcinoma cell growth and cytokine production in vitro by Toutirais, O, Gervais, A, Cabillic, F, Le Gallo, M, Coudrais, A, Levêque, J, Catros-Quemener, V, Genetet, N

“…The poor prognosis associated with ovarian carcinoma (OVCA) is linked to the high incidence of local recurrence. There is a pressing need to identify factors…”
Get full text

PHARMACOLOGICAL INHIBITION OF EZH2 SUPPRESSES PAIN IN MICE WITH MONOIODOACETATE-INDUCED OSTEOARTHRITIS BY REGULATING INFLAMMATION, OXIDATIVE STRESS, AND AUTOPHAGY IN SYNOVIAL CELLS by Brochard, S., Aury-Landas, J., Agin, V., Bernay, B., Pontin, J., Seillier, C., Toutirais, O., Cohen-Solal, M., Hay, E., Boumediene, K., Baugé, C.

Get full text

V gamma 9V delta 2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas by Bouet-Toussaint, F, Cabillic, F, Toutirais, O, Le Gallo, M, De La Pintiere, CT, Daniel, P, Genetet, N, Meunier, B, Dupont-Bierre, E, Boudjema, K, Catros, V

“…Introduction V gamma 9V delta 2 T lymphocytes are reported to participate in the anti-tumor immune surveillance in human. They are known to recognize…”
Get full text

Increase of Infusion Interval Do Not Impair Natalizumab Efficacy in RR-MS Patients: A Pilot Study Based on Monthly Monitoring of CD49d (P06.166) by Defer, G., Mariotte, D., Derache, N., Toutirais, O., Lamotte, G., Legros, H., Cauquelin, B., Le Mauff, B.

“…Abstract only…”
Get full text

HLA-A0201-restricted CEA-derived Peptide CAP1 Is Not a Suitable Target for T-cell-based Immunotherapy by FAUQUEMBERGUE, Emilie, TOUTIRAIS, Olivier, BAERT-DESURMONT, Stéphanie, LEPRINCE, Jérôme, VAUDRY, Hubert, SESBOUE, Richard, FREBOURG, Thierry, LATOUCHE, Jean-Baptiste, CATROS, Véronique, TOUGERON, David, DROUET, Aurélie, LE GALLO, Matthieu, DESILLE, Mireille, CABILLIC, Florian, DE LA PINTIERE, Cécile Thomas, IERO, Manuela, RIVOLTINI, Licia

“…Carcinoembryonic antigen (CEA) is a potential target for antigen-specific immunotherapy, as it is frequently overexpressed in human carcinomas. Moreover, an…”
Get full text

Constitutive expression of TGF-bêta1, interleukin-6 and interleukin-8 by tumor cells as a major component of immune escape in human ovarian carcinoma by Toutirais, Olivier, Chartier, Patricia, Dubois, Damien, Bouet, Françoise, Lévêque, Jean, Catros-Quemener, Véronique, Genetet, Noëlle

“…Tumors could use several mechanisms to coexist with the host's immune system or to protect themselves from an immune response. Thus, insufficient expression of…”
Get more information

ORIGINAL ARTICLE: Interleukin-6 and vascular endothelial growth factor release by renal cell carcinoma cells impedes lymphocyte-dendritic cell cross-talk by Cabillic, F, Bouet-Toussaint, F, Toutirais, O, Rioux-Leclercq, N, Fergelot, P, de la Pintiere, CThomas, Genetet, N, Patard, J-J, Catros-Quemener, V

“…Anti-tumour T cell response requires antigen presentation via efficient immunological synapse between antigen presenting cells, e.g. dendritic cells (DC), and…”
Get full text

Exploration des effets indésirables receveurs allergiques by Bazin, A., Mariotte, D., Vergnaud, M.-C., Lesage, A., Brunet, A., Toutirais, O., Dupuis, M., Hervé, I., Laroche, D.

Get full text

In Vitro Antitumor Lymphocyte Generation Using Dendritic Cells and Innate Immunity Mechanisms as Tumor Cell Treatments by GERVAIS, Alban, TOUTIRAIS, Olivier, BOUET-TOUSSAINT, Francoise, DE LA PINTIERE, Cecile Thomas, GENETET, Noelle, CATROS-QUEMENER, Veronique

“…Dendritic cells play a central role in the initiation and regulation of acquired and innate immunity, playing an important role in immunosurveillance and…”
Get full text

Étude rétrospective du seuil de positivité des alloanticorps anti-HLA dans des cas de transfusion related acute lung injury (TRALI) immunologiques probables grade 3 et 4 survenus entre 2007 et 2010 by Renac, V., Absi, L., Cesbron, A., Dautin, G., Delbos, F., Dubois, V., Giannoli, C., Hanau, D., Hau, F., Parissiadis, A., Picard, C., Quelvennec, E., Toutirais, O., Semana, G.

Get full text

Imagerie moléculaire de l’inflammation par IRM7T dans l’EAE : futur marqueur d’activité de la SEP ? by Montagne, A., Macrez, R., Gauberti, M., Haelewyn, B., Toutirais, O., Le Mauff, B., Vivien, D., Docagne, F., Defer, G.

Get full text

Ex Vivo Expansion of Antitumor Cytotoxic Lymphocytes with Tumor-associated Antigen-loaded Dendritic Cells by GERVAIS, Alban, BOUET-TOUSSAINT, Francoise, TOUTIRAIS, Olivier, DE LA PINTIERE, Cécile Thomas, GENETET, Noëlle, CATROS-QUEMENER, Véronique

“…Cell therapy with lymphocytes is an attractive approach for cancer immunotherapy. Methods to generate ex vivo effector cells directed against whole autologous…”
Get full text

Cytotoxic effector cells with antitumor activity can be amplified ex vivo from biopsies or blood of patients with renal cell carcinoma for cell therapy use by BOUET-TOUSSAINT, Francoise, PATARD, Jean-Jacques, GERVAIS, Alban, GENETET, Noëlle, DE LA PINTIERE, Cécile Thomas, RIOUX-LECLERCQ, Nathalie, TOUTIRAIS, Olivier, THIROUARD, Anne-Sophie, RAMEE, Marie-Paule, CATROS-QUEMENER, Véronique

“…Adoptive immunotherapy with antitumor effector cells is an attractive therapeutic approach in metastatic renal cell carcinoma (RCC). The aim of the work was to…”
Get full text